BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31173838)

  • 41. Cognitive dysfunctions in depression - significance, description and treatment prospects.
    Czerwińska A; Pawłowski T
    Psychiatr Pol; 2020 Jun; 54(3):453-466. PubMed ID: 33038880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: A systematic review.
    Cambridge OR; Knight MJ; Mills N; Baune BT
    Psychiatry Res; 2018 Nov; 269():157-171. PubMed ID: 30149273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of cognitive challenges in major depression: the role of the primary care physician.
    Mattingly G; Anderson RH; Mattingly SG; Anderson EQ
    Postgrad Med; 2016 Sep; 128(7):665-71. PubMed ID: 27500820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review.
    Evans VC; Iverson GL; Yatham LN; Lam RW
    J Clin Psychiatry; 2014 Dec; 75(12):1359-70. PubMed ID: 25551235
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram.
    Levada OA; Troyan AS
    J Affect Disord; 2019 May; 250():114-122. PubMed ID: 30852363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of computerized cognitive test battery in major depressive disorder: a narrative literature review.
    Cao B; Xiao M; Chen X; Zhao Y; Pan Z; McIntyre RS; Chen H
    Nord J Psychiatry; 2022 May; 76(4):263-271. PubMed ID: 34423722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Late-Life Depressive Symptoms and Lifetime History of Major Depression: Cognitive Deficits are Largely Due to Incipient Dementia rather than Depression.
    Heser K; Bleckwenn M; Wiese B; Mamone S; Riedel-Heller SG; Stein J; Lühmann D; Posselt T; Fuchs A; Pentzek M; Weyerer S; Werle J; Weeg D; Bickel H; Brettschneider C; König HH; Maier W; Scherer M; Wagner M;
    J Alzheimers Dis; 2016 Aug; 54(1):185-99. PubMed ID: 27497475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cognitive Performance in First-Degree Relatives of Individuals With vs Without Major Depressive Disorder: A Meta-analysis.
    MacKenzie LE; Uher R; Pavlova B
    JAMA Psychiatry; 2019 Mar; 76(3):297-305. PubMed ID: 30586133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice.
    Papakostas GI
    J Clin Psychiatry; 2014 Jan; 75(1):8-14. PubMed ID: 24345473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Routine clinical assessment of cognitive functioning in schizophrenia, major depressive disorder, and bipolar disorder.
    Belgaied W; Samp J; Vimont A; Rémuzat C; Aballéa S; El Hammi E; Kooli A; Toumi M; Akhras K
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):133-41. PubMed ID: 24314852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychosocial and neurocognitive profiles in depressed patients with major depressive disorder and bipolar disorder.
    Godard J; Grondin S; Baruch P; Lafleur MF
    Psychiatry Res; 2011 Dec; 190(2-3):244-52. PubMed ID: 21764461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field.
    Miskowiak KW; Ott CV; Petersen JZ; Kessing LV
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):1845-1867. PubMed ID: 27745932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multidimensional cognitive impairment in unipolar and bipolar depression and the moderator effect of adverse childhood experiences.
    Poletti S; Aggio V; Brioschi S; Dallaspezia S; Colombo C; Benedetti F
    Psychiatry Clin Neurosci; 2017 May; 71(5):309-317. PubMed ID: 28004481
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment and Management of Cognitive and Psychosocial Dysfunctions in Patients With Major Depressive Disorder: A Clinical Review.
    Fiorillo A; Carpiniello B; De Giorgi S; La Pia S; Maina G; Sampogna G; Spina E; Tortorella A; Vita A
    Front Psychiatry; 2018; 9():493. PubMed ID: 30364225
    [No Abstract]   [Full Text] [Related]  

  • 55. Sex difference in IL-6 modulation of cognition among Chinese individuals with major depressive disorder.
    Qu N; Zhang SF; Xia B; Xie JZ; Wang XM; Liu J; Xiong J; Ren N; Wang Y; Tian Q; Li Y
    J Clin Neurosci; 2019 Dec; 70():14-19. PubMed ID: 31629608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of desvenlafaxine on neurocognitive and work functioning in employed outpatients with major depressive disorder.
    Lam RW; Iverson GL; Evans VC; Yatham LN; Stewart K; Tam EM; Axler A; Woo C
    J Affect Disord; 2016 Oct; 203():55-61. PubMed ID: 27280963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder.
    Cha DS; Best MW; Bowie CR; Gallaugher LA; Woldeyohannes HO; Soczynska JK; Lewis G; MacQueen G; Sahakian BJ; Kennedy SH; Lui JP; Mansur RB; McIntyre RS
    J Affect Disord; 2017 Mar; 210():57-65. PubMed ID: 28013123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive function following a major depressive episode: a systematic review and meta-analysis.
    Semkovska M; Quinlivan L; O'Grady T; Johnson R; Collins A; O'Connor J; Knittle H; Ahern E; Gload T
    Lancet Psychiatry; 2019 Oct; 6(10):851-861. PubMed ID: 31422920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered fractional amplitude of low frequency fluctuation associated with cognitive dysfunction in first-episode drug-naïve major depressive disorder patients.
    Huang M; Lu S; Yu L; Li L; Zhang P; Hu J; Zhou W; Hu S; Wei N; Huang J; Weng J; Xu Y
    BMC Psychiatry; 2017 Jan; 17(1):11. PubMed ID: 28077120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytokine alterations and cognitive impairment in major depressive disorder: From putative mechanisms to novel treatment targets.
    Misiak B; Beszłej JA; Kotowicz K; Szewczuk-Bogusławska M; Samochowiec J; Kucharska-Mazur J; Frydecka D
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):177-188. PubMed ID: 28433456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.